Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted imidazole as bombesin receptor subtype-3 modulators

Substituted imidazole as bombesin receptor subtype-3 modulators

US Patent 8193228 · Granted Jun 5, 2012

Estimated economic value: $102,353,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

GPR40 agonists2025
AMPK activators2023
GPR119 agonists2022
Long-acting co-agonists of the glucagon and GLP-1 receptors2022
AMPK activators2022
AMPK activators2022
Substituted carbapenems for the treatment of bacterial infections2021
Insulin dimer-incretin conjugates2021
Glucose responsive insulin comprising a tri-valent sugar cluster for treatment o2021
Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,2021
Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2-negative al2020
Insulin receptor partial agonists2020